Protara Therapeutics (TARA) Stock Chart & Stock Price History → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free TARA Stock Alerts $2.83 -0.04 (-1.39%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Protara Therapeutics Stock Price Performance5 Day Performance-2.75%1 Month Performance-17.49%3 Month Performance-2.08%6 Month Performance+137.82%Year-To-Date Performance+50.93%1 Year Performance-8.41% Receive TARA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Unstoppable Prosperity“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. TARA Stock Chart for Wednesday, May, 8, 2024 TARA Chart by TradingView Protara Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$2.87$2.83-1.39%$2.95$2.80155,506 shs$32.35 million05/07/2024$2.90$2.87-1.03%$3.00$2.8780,072 shs$32.80 million05/06/2024$2.91$2.90-0.34%$3.03$2.88109,132 shs$33.15 million05/03/2024$2.89$2.91+0.69%$2.99$2.84118,886 shs$33.26 million05/02/2024$2.93$2.89-1.37%$3.00$2.85113,561 shs$33.03 million05/01/2024$2.98$2.93-1.68%$3.20$2.87250,728 shs$33.49 million Get the Latest News and Ratings for TARA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$3.10$2.98-3.87%$3.11$2.84280,350 shs$34.06 million04/29/2024$2.93$3.10+5.98%$3.16$2.86782,481 shs$35.43 million04/26/2024$3.05$2.92-4.26%$3.23$2.83254,929 shs$33.39 million04/25/2024$2.82$3.05+8.16%$3.05$2.75262,559 shs$34.86 million04/24/2024$3.00$2.82-6.00%$3.11$2.80422,081 shs$32.23 million04/23/2024$3.05$3.00-1.64%$3.18$2.82411,621 shs$34.29 million04/22/2024$2.64$3.05+15.53%$3.35$2.89536,374 shs$34.86 million04/19/2024$2.75$2.64-4.00%$2.80$2.61207,887 shs$30.18 million04/18/2024$2.73$2.75+0.73%$2.89$2.66241,473 shs$31.43 million04/17/2024$2.85$2.73-4.21%$2.84$2.70174,414 shs$31.22 million04/16/2024$2.84$2.85+0.35%$2.93$2.73133,639 shs$32.58 million04/15/2024$3.00$2.84-5.33%$3.02$2.82137,294 shs$32.46 million04/12/2024$3.09$3.00-2.91%$3.15$2.92144,474 shs$34.30 million04/11/2024$3.19$3.09-3.13%$3.19$2.93114,769 shs$35.32 million04/10/2024$3.22$3.19-0.93%$3.39$3.12130,328 shs$36.46 million04/09/2024$3.43$3.22-6.12%$3.44$3.16401,491 shs$36.81 million04/08/2024$3.63$3.43-5.51%$3.69$3.36354,093 shs$39.21 million04/05/2024$4.02$3.63-9.70%$5.24$3.568.57 million shs$41.49 million04/04/2024$4.10$4.02-1.95%$4.20$3.9830,820 shs$45.95 million04/03/2024$4.11$4.10-0.24%$4.15$4.0352,681 shs$46.86 million04/02/2024$4.14$4.11-0.72%$4.14$3.9541,939 shs$46.98 million04/01/2024$4.01$4.14+3.24%$4.14$3.9977,712 shs$47.32 million03/29/2024$4.01$4.01$4.10$3.9584,083 shs$45.83 million03/28/2024$4.00$4.01+0.25%$4.10$3.9583,563 shs$45.83 million03/27/2024$4.15$4.00-3.61%$4.23$3.9568,424 shs$45.72 million03/26/2024$3.99$4.15+4.01%$4.20$3.9285,958 shs$47.44 million03/25/2024$4.02$3.99-0.75%$4.12$3.9139,284 shs$45.61 million03/22/2024$3.90$4.02+3.08%$4.25$3.9685,262 shs$45.95 million03/21/2024$4.03$3.90-3.23%$4.22$3.89146,029 shs$44.58 million03/20/2024$4.00$4.03+0.75%$4.25$3.9052,908 shs$46.06 million03/19/2024$4.00$4.00$4.04$3.8788,610 shs$45.72 million03/18/2024$3.68$4.00+8.70%$4.13$3.73210,818 shs$45.72 million03/15/2024$3.57$3.68+3.08%$3.73$3.40106,606 shs$41.81 million03/14/2024$3.65$3.57-2.19%$3.72$3.4455,213 shs$40.57 millionRSVP: Charles Payne’s Cash Flow Workshop (Ad)Are you ready to find untapped value in the stocks you already own… Without selling a single share… Then you need to know these Cash Flow Trade Strategies.Register For Free Now!03/13/2024$3.57$3.65+2.24%$3.79$3.6055,077 shs$41.48 million03/12/2024$3.57$3.57$3.66$3.4550,263 shs$40.56 million03/11/2024$3.80$3.57-6.05%$3.92$3.4391,984 shs$40.56 million03/08/2024$3.83$3.80-0.78%$4.00$3.7632,217 shs$43.17 million03/07/2024$3.95$3.83-3.04%$4.16$3.7543,474 shs$43.51 million03/06/2024$3.74$3.95+5.61%$4.23$3.6523,887 shs$44.87 million03/05/2024$4.40$3.74-15.00%$4.42$3.63117,613 shs$42.49 million03/04/2024$4.60$4.40-4.35%$4.74$4.2281,835 shs$49.98 million03/01/2024$4.56$4.60+0.88%$4.72$4.3294,393 shs$52.26 million02/29/2024$4.47$4.56+2.01%$4.84$4.4046,441 shs$51.80 million02/28/2024$4.83$4.47-7.45%$4.91$4.33136,465 shs$50.78 million02/27/2024$4.69$4.83+2.99%$4.95$4.75154,623 shs$54.87 million02/26/2024$4.21$4.69+11.40%$4.70$4.25143,324 shs$53.28 million02/23/2024$4.08$4.21+3.19%$4.41$3.9784,653 shs$47.83 million02/22/2024$4.12$4.08-0.97%$4.33$3.9574,038 shs$46.35 million02/21/2024$3.99$4.12+3.26%$4.23$3.9070,311 shs$46.80 million02/20/2024$4.06$3.99-1.72%$4.42$3.87153,406 shs$45.33 million02/19/2024$4.06$4.06$4.10$3.47234,700 shs$46.12 million02/16/2024$3.53$4.06+15.01%$4.10$3.47233,336 shs$46.12 million02/15/2024$3.33$3.53+6.17%$3.62$3.32170,474 shs$40.12 million02/14/2024$2.89$3.33+15.05%$3.34$2.88133,745 shs$37.79 million02/13/2024$2.99$2.89-3.34%$2.98$2.8922,667 shs$32.83 million02/12/2024$3.05$2.99-1.97%$3.10$2.9845,285 shs$33.97 million02/09/2024$2.89$3.05+5.54%$3.19$2.8998,165 shs$34.65 million02/08/2024$2.68$2.89+7.84%$3.04$2.68107,527 shs$32.83 million02/07/2024$2.74$2.68-2.19%$2.80$2.6517,489 shs$30.45 million Related Companies: INKT Stock Price Chart SRZN Stock Price Chart NKGN Stock Price Chart INAB Stock Price Chart CRTX Stock Price Chart ACHL Stock Price Chart ESLA Stock Price Chart PLUR Stock Price Chart SABS Stock Price Chart DYAI Stock Price Chart Receive TARA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TARA) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.